INIS
patients
100%
epilepsy
73%
surgery
49%
brain
40%
humans
35%
hemorrhage
25%
drugs
24%
assessments
21%
control
19%
in vivo
18%
tissues
15%
comparative evaluations
15%
electrodes
15%
tumors
12%
biopsy
11%
quality of life
10%
ischemia
10%
hippocampus
10%
hospitals
9%
levels
9%
risks
8%
reviews
8%
symptoms
7%
death
7%
evaluation
7%
damage
7%
rats
7%
proteins
6%
injuries
6%
stimulation
6%
Keyphrases
Temporal Lobe Epilepsy
31%
Glycocalyx
27%
Resective Epilepsy Surgery
16%
Epilepsy Surgery
15%
Aneurysmal Subarachnoid Hemorrhage (aSAH)
14%
Drug-resistant Epilepsy
11%
Epilepsy Patients
11%
Brain Tissue
10%
Febrile Seizures
10%
Sidestream Dark Field Imaging
9%
Resective
8%
Brain Surgery
8%
Neuropathology
8%
Sublingual
7%
After Surgery
7%
Cerebral Microcirculation
6%
In Vivo Assessment
6%
Hippocampus
6%
Rebleeding
6%
Pathological Diagnosis
6%
Temporal Lobe
6%
Adverse Events
6%
Tumor
6%
Quality of Life
6%
Delayed Cerebral Ischemia
6%
Health Care Costs
6%
Intraoperative Assessment
5%
Conjunctival
5%
Blood-brain Barrier
5%
Healthcare
5%
Medicine and Dentistry
Epilepsy Surgery
26%
Subarachnoid Hemorrhage
13%
Aneurysm
12%
Stereoelectroencephalography
10%
Prospective Cohort Study
10%
Quality of Life
10%
Intracranial Aneurysm
10%
Drug Resistant Epilepsy
10%
Neoplasm
9%
Epileptic Seizure
7%
Adverse Event
6%
Craniotomy
6%
Health Care Cost
5%
Microcirculation
5%
Aneurysm Clipping
5%
Glycocalyx
5%
Glioblastoma
5%
Brain Tissue
5%
Health Care
5%
Anterior Temporal Lobectomy
5%
Neuroepithelioma
5%
Headache
5%
Hemangioma
5%
Visual Field
5%
Condylar Fracture
5%
Compartment Syndrome
5%
Systematic Review
5%
Cerebrospinal Fluid
5%
Cortical Dysplasia
5%
Brain Surgery
5%
